GlassScriptPhysician profile
Thomas H Swanson
NPI 1376535575
$10,850.81
in general payments reported to CMS, 2019-2025
10 companies · $300 in 2025
The $300 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,602 · 2020: $62.33 · 2021: $3,942 · 2022: $78.77 · 2023: $1,188 · 2024: $677 · 2025: $300.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,423 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,422.95 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $742.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $7,879.09 | 2019-2021 | |
| Livanova USA, INC. | $1,245.78 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Catalyst Pharmaceuticals, INC. | $624.74 | 2023-2024 | Fycompa |
| Jazz Pharmaceuticals INC. | $402.54 | 2024-2025 | |
| Ucb, INC. | $315.76 | 2021-2025 | Fintepla |
| Sunovion Pharmaceuticals INC. | $156.35 | 2019 | |
| Zogenix INC. | $102.00 | 2021 | |
| Greenwich Biosciences, INC. | $78.67 | 2019 | |
| Abbvie INC. | $28.56 | 2025 | |
| Sk Life Science, INC. | $17.32 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.